Cost Comparison Table Insurance Coverage Saxenda: FDA-approved for weight loss Some plans cover with prior authorization May have quantity limits or step therapy requirements Ozempic: FDA-approved for diabetes, not weight loss Often covered for diabetic patients Rarely covered for weight loss alone Wegovy: FDA-approved for weight loss Coverage varies widely Many plans exclude weight loss medications Cost Efficiency When comparing cost per outcome: Saxenda: At $200/month for 12 months ($2,400) producing 15-18 pounds loss = ~$133-160 per pound lost Semaglutide: At $199/month for 12 months ($2,388) producing 30-35 pounds loss = ~$68-80 per pound lost Semaglutide provides substantially better value when considering weight loss achieved per dollar spent
This is the shade that thousands of people see when they open their vials from reputable compounding pharmacies
A study published in the journal Obesity Science and Practice examined weight reduction and treatment adherence in patients using tirzepatide under the IVIM protocol
doi: 10.1016/S0140-6736(98)07019-6 124 The Diabetes Control and Complications Trial Research Group
Facial volume loss from medications like Ozempic and Wegovy can be either temporary or permanent, depending on the extent of weight loss and how the body responds
In the development of dulaglutide, alanine at position 8 in the native GLP-1 sequence was substituted with valine, and the peptide was fused to the Fc domain of immunoglobulin G to confer resistance to DPP-4 degradation
